CHDI Foundation, Inc. has extended its collaboration with Evotec AG through 2017 for the discovery of new treatments for Huntington’s disease. CHDI will fund as many as 52 full-time scientists at Evotec for the next three years.   Initiated in 2006, the collaboration has expanded to fully leverage Evotec’s integrated neuroscience platform and now further expands the use of Evotec’s high-throughput screening and proteomics platforms. Evotec provides a research activities to CHDI...